Concepedia

Dose-proportionality Assessment

Dose-Proportionality Assessment is a pharmacokinetic evaluation method that determines whether the systemic exposure to a drug increases in direct proportion to an increase in dose, within a specified dosage range, under defined conditions of administration.

60

Publications

3.2K

Citations

293

Authors

106

Institutions

Publications per year

2017–2026

6

Variants

Dose Proportionality Assessment

Parents

Children

Publications

60

The Linear-Quadratic Model Is an Appropriate Methodology for Determining Isoeffective Doses at Large Doses Per Fraction

David J. Brenner · Seminars in Radiation Oncology · 2008 · 538 citations · Full text

, , +10

Confidence Interval Criteria for Assessment of Dose Proportionality

Brian P. Smith · Pharmaceutical Research · 2000 · 352 citations

, , +13

Dose equivalence of the anti-psychotic drugs

John M. Davis · Journal of Psychiatric Research · 1974 · 324 citations

, , +13

Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party

Kevin Gough, Michael G. Hutchison, Oliver N. Keene et al. · Drug Information Journal · 1995 · 266 citations

, , +12

SIMPLIFICATION OF DRUG DOSAGE CALCULATION BY APPLICATION OF THE SURFACE AREA PRINCIPLE

John D. Crawford, Mary E. Terry, G. Margaret Rourke · PEDIATRICS · 1950 · 169 citations

, , +16

1–5 of 60

Authors

293

  1. LS
    Lisa Squassante

    GlaxoSmithKline (Italy), Italy

    2 publications · 54 citations

    2

    h-index

  2. KB
    Kerstin Breithaupt‐Grögler

    Goethe University Frankfurt, Germany

    2 publications · 107 citations

    2

    h-index

  3. GG
    G. G. Belz

    Goethe University Frankfurt, Germany

    2 publications · 107 citations

    2

    h-index

  4. JF
    James F. McLeod

    Novartis (Switzerland), Switzerland

    2 publications · 52 citations

    2

    h-index

  5. CJ
    C. J. Timmer

    AkzoNobel (Netherlands), Netherlands

    2 publications · 87 citations

    2

    h-index

1–5 of 293

Institutions

106

  1. Novartis (Switzerland)

    Basel, Switzerland

    5 h-index

    9 publications

    165 citations

  2. Research Triangle Park Foundation

    Durham, United States

    3 h-index

    4 publications

    86 citations

  3. GlaxoSmithKline (United States)

    Philadelphia, United States

    3 h-index

    13 publications

    226 citations

  4. United States Military Academy

    West Point, United States

    2 h-index

    4 publications

    135 citations

  5. Massachusetts General Hospital

    Boston, United States

    2 h-index

    4 publications

    546 citations

  6. Indiana University – Purdue University Indianapolis

    Indianapolis, United States

    2 h-index

    8 publications

    1.1K citations

  7. Bhabha Atomic Research Centre

    Mumbai, India

    2 h-index

    8 publications

    304 citations

  8. Novartis (France)

    Rueil-Malmaison, France

    2 h-index

    2 publications

    30 citations

1–8 of 106

Venues

  1. The Journal of Clinical Pharmacology

    5 publications · 156 citations

    5

    h-index

  2. European Journal of Clinical Pharmacology

    3 publications · 66 citations

    3

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 2 publications · 73 citations

    2

    h-index

  4. Drug Information Journal

    DIA · 2 publications · 278 citations

    2

    h-index

  5. Clinical Therapeutics

    2 publications · 78 citations

    2

    h-index

1–5